(Story on A4)
DUTERTE CHIDES CHINA FOR ‘BULLY’ ACTION IN SOUTH CHINA SEA (See story below) Vol. 35
n
No. 286 No.286
18 .00
2 SECTIONS
November 28, 2021 10 PAGES
IN MET R MANILAO
BORDER CONTROL.
A Personnel from the Overseas Workers Welfare Administration (OWWA) checks the health declaration and other documents of a newly-arrived balikbayan at the Terminal 1 of Ninoy Aquino International Airport in Paranaque City on Saturday, Nov. 27, 2021. Overseas Filipino workers begin arriving im the country to spend the Christmas holidays with their families and relatives here as the government moves to tighten border controls amid the new COVID-19 variant of concern Omicron. Danny Pata
OMICRON GRIPS WORLD
DOH seeks HK flights halt; Alert Level 2 in Dec. eyed
T
WHO tags it ‘most troubling variant of concern as Delta’
THE World Health Organization has declared the recently-discovered B.1.1.529 strain of COVID-19, first detected in southern Africa, to be a variant of concern and renamed it Omicron. The classification puts Omicron into the most-troubling category of COVID-19 variants, along with the globally-dominant Delta, plus its weaker rivals Alpha, Beta and Gamma. Nations rushed to ban flights to slow the spread of Omicron on Friday, while stock markets and oil prices plunged on fears surrounding the variant, potentially dealing a heavy blow to the global economic recovery. Dutch health authorities said Saturday that 61 passengers aboard two KLM flights from South Africa tested positive for COVID-19 and the results were being examined for the new Omicron variant. The positive cases – more than one tenth of the 600 people on the two planes – were now being quarantined in a hotel near Amsterdam’s Schiphol Airport, one of Europe’s biggest international air travel hubs.
n By B VITO BARCELO
HE Department of Health recommended expanding the travel ban to Hong Kong after the detection of the coronavirus variant of concern Omicron in the territory.
Health Secretary Francisco Duque III said he has already submitted a formal recommendation to Executive Secretary Salvador Medialdea to include Hong Kong in the list of countries covered by the ban, which currently covers South Africa, Botswana, Namibia, Zimbabwe, Lesotho, Eswatini, and Mozambique. “We are waiting for the approval of our recommendation. We have many OFWs [overseas Filipino workers] who would want to come home for Christmas,” Duque said as Hong Kong recorded Thursday its first two cases of Omicron, which has been
found to have 32 spike protein mutations compared to the 13 to 17 seen in the Delta variant. A member of the independent OCTA Research Group on Saturday also appealed to the government to keep the entire country under Alert Level 2 until January next year amid the threat of the Omicron variant. “If we can remain at Alert Level 2, that would make us ready just in case [we detect the presence of Omicron in the country] and we can contain the spread,” OCTA member Dr. Guido David said. CONTINUED ON 3A
Drug firm Moderna to develop booster shot against new threat THE US pharmaceutical company Moderna said it will develop a booster shot against the new Omicron variant of the coronavirus. It is one of three strategies the company is working to address the new threat, including a higher dose of its existing vaccine, Moderna said. "The mutations in the Omicron variant are concerning and for several days, we have been moving as fast as possible to execute our strategy to address this variant," said Moderna CEO
COVID-19 PH AT
A
GLANCE
2,831,177 899
17,052
48,205
188
2,765,920
1,667
New
Active
Death
New
Recoveries
New
(As of 4 PM, NOV. 27)
I
N
S
I
D
Stephane Bancel. Meanwhile, an anti-COVID pill developed by Merck has proved effective in treating the disease, the US Food and Drug Administration said in a much-awaited preliminary report. But the report, from an FDA advisory panel, cautioned that pregnant women should not use the drug, known as molnupiravir, saying the potential benefits do not outweigh the risks for those patients. The report is meant to provide guidance to an FDA experts panel convening Tuesday to consider whether to authorize emergency use of molnupiravir. Approval, analysts say, would represent a major step forward in thebattle against the global pandemic, handing healthcare professionals a powerful new tool to help those infected. Merck released the full results of the drug's clinical trial Friday, which found the pill would reduce by 30 percent – much lower than its initial figure – the rate of hospitalizations and deaths in high-risk COVID patients who took it soon after infection. The preliminary FDA report confirmed the drug's effectiveness in patients with mild to moderate COVID or at risk of hospitalization. CONTINUED ON 3A
E
Business ................................................................. Sports.......................................................................... Entertainment ......................................... Pets...................................................................................
4A 1B 3B 4B
In Germany, a regional official said Saturday that health authorities have identified the first suspected case in the country of the Omicronvariant in a person who returned from South Africa. “The Omicron variant has with strong likelihood already arrived in Germany,” Kai Klose, social affairs minister in the western state of Hesse, tweeted, referring to the strain first detected in southern Africa. Klose said that tests late Friday on the traveler who had returned to Germany from South Africa revealed “several mutations typical of Omicron.” The WHO said it could take several weeks to complete studies of Omicron to see if there are any changes in transmissibility, severity or implications for COVID vaccines, tests and treatments. “Based on the evidence presented indicative of a detrimental change in COVID-19 epidemiology... the WHO has designated B.1.1.529 as a variant of concern (VOC), named Omicron,” the UN health agency said in a statement. CONTINUED ON 3A
40% LESS. A lack in syringes for the Pfizer vaccine against COVID-19 has prompted the government to slash its target during the three-day National Vaccination Days from 15 million jabs to only 9 million.
Lack of syringe lowers Nat’l Vax Day target n By VITO BARCELO AND JOEL ZURBANO DUE to a shortage in ancillary supplies, particularly syringes for Pfizer-BioNTech vaccines, the government adjusted its target of 15million jabs to only 9 million for the three day National Vaccination Days from Nov. 29 to
Dec. 1, the National Task Force (NTF) Against COVID-19 said. To achieve the goal of completely inoculating 54 million Filipinos by yearend, the NTF and National Vaccination Operations Center set another three-day inoculation drive on Dec. 15 to 17. In a statement, the NTF and the NVOC said they adjusted the target after consulting local chief executives
Duterte chides China for ‘bully’ act in SCS n By VITO BARCELO
PRESIDENT Rodrigo Duterte said there can be no real peace if strong nations bully the weak
as he reminded fellow leaders participating in the 13th Asia-Europe Meeting that the rule of law should prevail in areas where there are maritime disputes.
“There can be no real peace if the strong trample on the weak – just because it can,” Duterte said without naming China, whose Coast Guard vessels CONTINUED ON 3A
of provinces, cities, and municipalities, as well as their resource management and logistics team.
PRESIDENT RODRIGO DUTERTE
CONTINUED ON 3A